Neuroscience Trials Australia (NTA)

NTA (Neuroscience Trials Australia) is an Australian-owned, niche contract research organization (CRO) specializing in neuroscience clinical research and beyond. NTA supports pharmaceutical, biotechnology, cell therapy and device companies to undertake their phase I-IV clinical trials according to global regulatory standards, including the TGA, FDA and EMA. Our therapeutic areas of expertise include epilepsy, stroke and stroke-related conditions, multiple sclerosis, Alzheimers, dementia, psychotic disorders, Parkinsons, brain and spinal cord injury, Huntingtons, neurosurgery, pain, mental health, neuromuscular diseases and migraine. NTA partners with The Florey Institute of Neuroscience and Mental Health, the largest brain research institute in the southern hemisphere, which facilitates...

Neuroscience,project management,stroke and stroke-related conditions,mental health,multiple sclerosis,parkinson’s disease,neurosurgery,pain,migraine,brain and spinal cord injury,huntington's,dementia,psychedelics,epilepsy,clinical trials,neuro-oncology,neuromuscular disease,psychotic disorders,ophthalmology,and devices

Neuroscience trials australia (nta) operates in the Research services industry.

Neuroscience trials australia (nta)'s revenue is 11m - 100m

Neuroscience trials australia (nta) has 11 - 50 employees.